Key Takeaways
- • Ares Management (ARES) has significantly underperformed broad market benchmarks, declining 25.3% year-to-date and 27% over the past 52 weeks, while the Dow Jones Industrial Average gained 7.5% YTD and 21.3% over the past year.
- • Stock has retreated to 52-week lows near $105.89, with the 52-week trading range spanning $95.80 to $195.26, reflecting substantial volatility and a loss of nearly one-third of its peak valuation.
- • Analyst consensus remains moderately constructive despite technical weakness, with a consensus price target of $146.39 implying 30% upside from current levels, though the technical rating is weak and relative strength has lagged most stocks.
- • Valuation metrics suggest potential undervaluation, with a forward P/E of 16.19 and a dividend yield of 4.62%, while the company maintains a market capitalization of $38.56 billion and a solid track record in institutional capital raising.
- • Fundamental profile shows mixed signals: growth scores are solid and high-growth momentum ratings are above average, but profitability and health ratings remain incomplete, indicating structural concerns beyond temporary market volatility.
Summary
Ares Management Corporation (ARES) has materially underperformed the broader equity market throughout 2026, presenting a stark contrast to gains in major indices. The stock has declined 25.3% year-to-date and fallen 27% over the trailing 52-week period, significantly lagging the Dow Jones Industrial Average's 7.5% YTD gain and 21.3% annual return. This performance gap reflects sustained weakness in the alternative asset management sector and, more specifically, investor concerns regarding Ares' operational execution and growth trajectory relative to peers.
The technical picture for ARES remains challenged. The stock exhibits weak relative strength, meaning it has lagged most equities over the past year, and the technical rating does not currently support a strong case for near-term appreciation. Trading has been volatile, with the stock touching a 52-week low of $105.89 and maintaining a wide intra-year range from $95.80 to $195.26—a span indicating investor uncertainty about fair valuation. At current levels near $121.38, the stock trades 34.31% below its one-year high, reflecting a significant loss of shareholder value from peak levels.
Despite this weakness, the fundamental investment case retains some merit for contrarian investors. Analysts maintain a consensus "Moderate Buy" rating with an average price target of $146.39, implying approximately 30% upside potential. The company's forward P/E ratio of 16.19 and dividend yield of 4.62% suggest the stock may be trading at a discount to intrinsic value, particularly given Ares' solid market position as a leading alternative asset manager with a capital-light business model. The company has demonstrated institutional fundraising strength, recently raising $8.5 billion for its Pathfinder III fund, and maintains a $38.56 billion market capitalization.
However, structural concerns temper the bullish narrative. Fundamental ratings are only somewhat weak, but profitability and health metrics lack the strength investors typically require in a best-in-class asset manager. Growth scores are solid and high-growth momentum ratings exceed average levels, but these cannot fully offset concerns regarding operational efficiency and competitive positioning. The combination of weak technicals, sector headwinds, and incomplete quality metrics suggests that while the stock may ultimately prove undervalued at current levels, near-term catalysts for a sustained reversal remain unclear.
The technical picture for ARES remains challenged. The stock exhibits weak relative strength, meaning it has lagged most equities over the past year, and the technical rating does not currently support a strong case for near-term appreciation. Trading has been volatile, with the stock touching a 52-week low of $105.89 and maintaining a wide intra-year range from $95.80 to $195.26—a span indicating investor uncertainty about fair valuation. At current levels near $121.38, the stock trades 34.31% below its one-year high, reflecting a significant loss of shareholder value from peak levels.
Despite this weakness, the fundamental investment case retains some merit for contrarian investors. Analysts maintain a consensus "Moderate Buy" rating with an average price target of $146.39, implying approximately 30% upside potential. The company's forward P/E ratio of 16.19 and dividend yield of 4.62% suggest the stock may be trading at a discount to intrinsic value, particularly given Ares' solid market position as a leading alternative asset manager with a capital-light business model. The company has demonstrated institutional fundraising strength, recently raising $8.5 billion for its Pathfinder III fund, and maintains a $38.56 billion market capitalization.
However, structural concerns temper the bullish narrative. Fundamental ratings are only somewhat weak, but profitability and health metrics lack the strength investors typically require in a best-in-class asset manager. Growth scores are solid and high-growth momentum ratings exceed average levels, but these cannot fully offset concerns regarding operational efficiency and competitive positioning. The combination of weak technicals, sector headwinds, and incomplete quality metrics suggests that while the stock may ultimately prove undervalued at current levels, near-term catalysts for a sustained reversal remain unclear.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.